Daniela Alejandra Quinteros

Daniela Alejandra Quinteros

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniela Alejandra Quinteros has a total of 142 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel Alberto Allemandi

    Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET and Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000 Córdoba, Argentina

    7 shared publications
  • Daniel Alberto Allemandi

    Department of Pharmacy, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, CONICET, Edificio de Ciencias II, Ciudad Universitaria, (5000) Córdoba, Argentina

    7 shared publications
  • Santiago Daniel Palma

    Departamento de Farmacia. Facultad Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA-CONICET), Universidad Nacional de Córdoba, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina

    6 shared publications
  • Daniel A. Allemandi

    5 shared publications
  • Santiago Daniel Palma

    Unidad de Investigación y Desarrollo en Tecnología Farmacéutica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba X5016JXA, Argentina

    5 shared publications
  • Sofia Mickaela Martinez

    Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina

    4 shared publications

Latest Publications

  • Open Access

    3D-Printed Master Template-Assisted Fabrication of Bilayer Dissolving Microneedles for Enhanced Spatial Confinement and Transdermal Delivery of Melatonin

    by Valentin Roldan Julian, Maria Sol Magi, Marcelo Ricardo Romero, Alvaro Jimenez-Kairuz, Daniel Allemandi, Daniela Alejandra Quinteros

    Transdermal administration of melatonin provides an attractive route to bypass gastrointestinal degradation and extensive hepatic clearance; however, passive diffusion is severely restricted by the lipophilic stratum corneum, while traditional monolayer microneedles suffer from extensive drug retention in non-penetrating baseplates. Here, we engineered a bilayer dissolving microneedle system fabricated via high-resolution masked stereolithography 3D-printed master templates and two-step centrifugal micromolding. The resulting hyaluronic acid and polyvinyl alcohol (HA-PVA, 1.5:1 w/w) microneedles presented sharp geometries (tip diameter 88% penetration efficiency, depositing payload at depths of 700–740 µm followed by a rapid dissolution matrix (>60% within 7 min; >82% at 2 h). In ex vivo Franz diffusion studies across porcine ear skin, optimized HA-PVA-MEL patches produced rapid systemic-like entry, reaching 51% cumulative permeation within 0.5 h and 90% at 2 h, outperforming conventional passive emulgel formulations by >100-fold. This bilayer architecture solves critical baseplate drug wastage while ensuring robust skin penetration and rapid transdermal flux, offering a clinically viable delivery platform for chronobiological therapies.

  • Open Access

    Innovative Designs of Multimodal Imaging Based on Radionuclide, Quantum, and Cargo-Loaded Nanoplatform Emitters Towards Enhanced Energy–Matter Interactions for Photonics and Bioassays

    by Marcelo R. Romero, Daniela A. Quinteros, A. Guillermo Bracamonte

    This mini-review is intended to show how multimodal imaging could be developed from prototypes and proofs of concept by controlling the nanoscale for improved resolution of life science imaging for broad applications such as bioassays, early diagnoses and further applications. It intends to afford the presentation of multimodal approaches for imaging and bioimaging uses with potential applications to biological media. The application of multimodal nanoemitters provides enhanced bioimaging through the generation of various targeted and well-defined signals. Radionuclides and luminescent emitters were considered in the discussion for improved and enhanced signaling. In this manner, we intended to show the increase in the power of information by collecting varied optical signal–matter interactions. This could be important for Positron Emission Tomography and Computed Tomography (PET-CT), Fluorescence Tomography (FT), and other new modes of imaging contemplating the incorporation of nanotechnology. In the context of the design of new multimodal energy modes, key examples were shown from the literature, where the interactions of different energy modes could lead to enhanced and improved signaling. Electromagnetic fields and nanoplasmonics are involved in these different energy modes involving varied quantum particle interactions with modified properties. In this regard, multimodal imaging has experienced developments in nanoemitters and nanobiolabeling to track biomolecular events and targeted cells. A large quantity of research output actually focuses on nano- and quantum emissions. However, there are not as many studies dealing with enhanced emissions or laser emissions coupled with radionuclide emitters. A non-classical form of light emission, considering varied luminescent phenomena as well as further quantum signaling, showed interesting and high-impact perspectives when combined with nuclear emissions. This is the case for current trends focusing on innovative single-cell analysis. For example, the characterization and diagnosis of cells where the targeting of antibody–antigen interactions is required, providing light and energy from different sources to produce different details and imaging resolutions, has been noted. These are potential approaches that could be developed through various strategies targeting life science applications. In this regard, this article puts forward a discussion focused on nanotechnology contemplating radio-pharmacy and enhanced nanoemitters.

  • Open Access

    Localized Ciprofloxacin Release by a Multifunctional Scaffold applied on Bone Regeneration: Assessment of Bioactivity, Biocompatibility, and Antibacterial Properties

    by Ana Della Rosa, Candelaria Torres Bessega, Noelia D´ Elía, Gabriela Sica, Daniela Alejandra Quinteros, Luciano Benedini

    Bone defects resulting from injuries or pathologies necessitate advanced filler materials that have evolved from passive integration to active roles in osseointegration and osteoinduction. This study presents the development of a multifunctional composite scaffold based on synthetic nano-hydroxyapatite (HA), sodium alginate (ALG), and calcium phosphate/carbonate cements (CPC) loaded with ciprofloxacin (CIP). The physicochemical behavior was assessed under simulated physiological conditions, revealing a pH-responsive performance: the scaffold maintains initial stability and high swelling at pH 7.4, while undergoing accelerated degradation at pH 4.2, mimicking the environment of active bone resorption. Optical microscopy with crossed polarizers confirmed the formation of birefringent three-dimensional structures (mesophases) that reinforce the matrix and provide a template for tissue organization. Bioactivity assays in simulated body fluid (SBF) demonstrated the progressive growth of biogenic hydroxyapatite, with extensive surface coverage achieved after 28 days, as validated by FE-SEM, XRD, and FT-IR analysis. Furthermore, the system ensures localized CIP release effective against the primary strains causing osteomyelitis while maintaining a hemolysis rate below 1%, confirming its excellent hemocompatibility. These findings establish this integral platform as a promising and safe antibacterial bone filler for localized tissue repair.

  • Carvacrol-loaded liquid crystalline nanoparticles based on phytantriol and Peceol®: A novel nanoplatform for controlled drug delivery and synthetic luminescence

    by Ayelen Inda, Carolina D.V Bessone, Carolina Aloisio, Sofía M. Martinez, Cecilia Tettamanti, A. Guillermo Bracamonte, Santiago Fernandez Bordín, Rafael G. Oliveira, Daniel A. Allemandi, Soledad Ravetti, et al.


  • Open Access

    Chitosan-TPP Nanogels for Ocular Delivery of Folic Acid: Release Profile, Corneal Permeation, and Mucoadhesion Assessment

    by Sebastián G. Bruno, Sofía M. Martínez, Camila Costa Gobbato, Daniela A. Quinteros, Agustina Alaimo, Oscar E. Pérez

    Background: Folic acid (FA) is essential for cellular functions but has limited ocular bioavailability, restricting its therapeutic effectiveness. Objective: To develop chitosan (CS)-based nanogels (NGs) for FA transport and release, with corneal permeation evaluation. Methods: NGs’ hydrodynamic diameter (Ho) and polydispersity index (PdI) were determined using dynamic light scattering (DLS). CS-FA interaction was confirmed by Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA) was applied for the dehydrated material characterization. Scanning electron microscopy (SEM) was used to evaluate the NGs ultraestructure. In vitro drug release studies were performed using a modified Franz diffusion cell, and the release profile was fitted to obtain kinetics parameters. Mucoadhesion properties were evaluated through ζ-potential measurements. Ex vivo corneal permeation studies were conducted in rabbit corneas to compare the permeability of FA contained in NGs. Results: NGs presented a Ho of 312.4 ± 8.2 nm and a PdI of 0.28 ± 0.04. SEM imaging revealed spherical morphologies with minor variations in size and shape induced by FA. Lyophilized and resuspended NGs exhibited a 6.8% increase in Ho and a PdI rise to 0.42, indicating slight aggregation. In vitro drug release studies demonstrated sustained FA release, as determined by the Higuchi model. Mucoadhesion studies showed a decrease in ζ-potential from +36.9 to +18.1 mV, confirming electrostatic interactions with mucin. Ex vivo corneal permeation studies indicated that encapsulated FA permeated 2.6 times slower than free FA, suggesting sustained release. Conclusions: our findings demonstrate the potential of nanostructures in the form of NGs to enhance FA-loaded ocular delivery and bioavailability.


  • Open Access

    Chitosan-TPP Nanogels for Foli Acid Ocular Delivery: Release Profile, Corneal Permeation, and Mucoadhesion Assessment

    by Sebastián G. Bruno, Sofía M. Martínez, Camila Costa Gobbato, Daniela A. Quinteros, Agustina Alaimo, Oscar E. Pérez

    Folic acid (FA) is essential for cellular functions but has limited ocular bioavailability, which restricts its therapeutic effectiveness. This study developed chitosan-based nanogels (NG) as FA carriers, evaluating their mucoadhesion, drug release, and corneal permeation. Freshly prepared NGs had a hydrodynamic diameter of 312.4 ± 8.2 nm and a polydispersity index (PdI) of 0.28 ± 0.04, determined by Dynamic Light Scattering (DLS). FA encapsulation was confirmed through Fourier Transform Infrared (FTIR) spectros-copy, Differential Scanning Calorimetry (DSC), and Thermogravimetric Analysis (TGA). Scanning Electron Microscopy (SEM) revealed a uniform spherical morphology with minor variations in size and shape upon FA entrapment. Freeze-dried NG showed a 6.8% of size increase and PdI rise to 0.42, indicating aggregation within acceptable limits. In vitro drug release studies using a modified Franz diffusion cell demonstrated sustained FA release whose profile was fitted with Higuchi model. Mucoadhesion studies, carried out by ζ-potential measurements, revealed a decrease from +36.9 to +18.1 mV, confirming electrostatic interactions with mucin. Ex vivo corneal permeation in rabbits showed that encapsulated FA permeated 2.6 times slower than free FA, indi-cating sustained release. In conclusion, our findings demonstrate the potential of FA-loaded NG to enhance ocular drug delivery and bioavailability.


  • Open Access

    Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model

    by Sofia Mickaela Martinez, Ayelen Inda, Maximiliano Nicolás Ríos, Carolina del Valle Bessone, Abril Bruera Bossio, Mario Eduardo Guido, José Domingo Luna Pinto, Daniel Alberto Allemandi, Daniela Alejandra Quinteros

    Background/Objectives: Neurodegenerative ocular diseases, such as age-related macular degeneration (AMD) and glaucoma, represent growing public health concerns. Oxidative stress plays a key role in their development, damaging retinal cells and accelerating disease progression. Melatonin (Mel) is a potent antioxidant with neuroprotective properties; however, it faces limitations such as low solubility. This study proposes the use of human serum albumin nanoparticles (Np-HSA) to enhance the delivery of Mel to the posterior segment of the eye and evaluates its neuroprotective and anti-apoptotic effects on the retina. Methods: A model of retinal degeneration was induced in New Zealand albino rabbits using cytotoxic and oxidative agents. Np-HSA-Mel nanoparticles were administered subconjunctivally, and cellular viability and retinal functionality were assessed using flow cytometry and pupillary light reflex (PLR). Histological and immunohistochemical studies, including the TUNEL assay, were performed to analyse cell survival and apoptotic index. Results: Np-HSA-Mel significantly preserved pupillary function and cell viability, demonstrating lower apoptosis compared to Mel solution and Np-HSA alone. Histologically, eyes treated with Np-HSA-Mel exhibited fewer structural alterations and greater cellular organisation. The TUNEL assay confirmed a significant reduction in the apoptotic index of retinal ganglion cells (RGCs) treated with Np-HSA-Mel. Conclusions: Np-HSA-Mel effectively overcame ocular barriers, achieving greater neuroprotective efficacy at the retinal level. These findings highlight the synergistic potential of albumin and Mel in treating neurodegenerative ocular diseases, opening new perspectives for future therapies.


  • Evidence of the protective role of Carvacrol in a retinal degeneration animal model

    by Ayelen Inda, Sofía Martinez, Carolina Bessone, Maximiliano Rios, Mario Guido, Rocío Herrero-Vanrell, Jose Domingo Luna, Daniel Allemandi, Soledad Ravetti, Daniela Quinteros


  • Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment

    by Reinaldo Vallejo, Daniela Quinteros, Javier Gutiérrez, Sofía Martínez, Soraya Rodríguez Rojo, Luis Ignacio Tártara, Santiago Palma, Francisco Javier Arias


  • Open Access

    Implantable Devices, Nano-, and Micro-Capsules for Future Nanomedicine and Life Sciences Nano-Tools

    by Luna Rocio Gomez Palacios, Martin Amé, Sofia Martinez, Cecilia Tettamanti, María Valeria Amé, Daniela Quinteros, Angel Guillermo Bracamonte

    In this communication the concept of functional materials is understood such as real modified substrates for nanomedicine applications. Functional and modified substrates focused on microcapsules and devices for new nanomedicine diagnosis and treatments. Cases of different materials are shown to support the functionality strategy, as in particular chemicals, pharmacophores, and controlled nano-chemistry for the design of nanoplatforms. Recent studies have reported hybrid inorganic/organic compositions for biocompatible, biodegradable, and support materials added to particular physical properties such as conductive, semiconductive, and high electromagnetic fields from the near field within the nanoscale to far-field applications and new nano-pharmacophores and nanomedicine therapeutics. New approaches are shown from the nano-scale to the micro- and higher sizes of substrates for improved therapeutic strategies. Micro-capsules for biosensing and drug delivery applications were developed. In addition, we report recent and novel research centered on implantable, portable, and wearable devices applied to future treatments.